Exact Sciences Corp (EXAS)

130.52 +3.38  +2.66% NASDAQ Apr 15, 20:00 USD
View Full Chart
Price Chart
View All EXAS News

News

View All Events

Events

Date Type Description
05/06/2020 17:00 EDT Earnings Calls Q1 2020 Earnings Call
05/06/2020 00:00 Earnings Results Q1 2020 Earnings Results
07/23/2020 11:00 EDT Agm 2019 Annual General Meeting
07/30/2020 17:00 EDT Earnings Calls Q2 2020 Earnings Call
07/30/2020 00:00 Earnings Results Q2 2020 Earnings Results
10/29/2020 17:00 EDT Earnings Calls Q3 2020 Earnings Call
10/29/2020 00:00 Earnings Results Q3 2020 Earnings Results
02/16/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/16/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
05/04/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.
  • URL: https://www.exactsciences.com
  • Investor Relations URL: https://investor.exactsciences.com/investor-relations/default.aspx
  • HQ State/Province: Wisconsin
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: May. 04, 2021
  • Last Earnings Release: Feb. 16, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ARKG ARK Genomic Revolution ETF 4.91%
DFRIX Delaware Smid Cap Growth R 4.33%
BBH VanEck Vectors Biotech ETF 4.29%
FBT First Trust NYSE Arca Biotech ETF 3.23%
ETCGX Eventide Gilead C 3.10%
GOFFX Invesco Global Opportunities R5 2.84%
EARK.NO Emerge ARK Global Disruptive Innovt ETF 2.78%
ARKK ARK Innovation ETF 2.78%
APDMX Artisan Mid Cap Advisor 2.41%
ZUH.TO BMO Eq Wght US HlthCare Hdgd to CAD ETF 2.22%
TRUZX T. Rowe Price New Horizons Z 2.07%
JMGQX JPMorgan Mid Cap Growth R4 1.15%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.